Now showing items 1-2 of 2

  • Immunosuppressive agents in adult kidney transplantation in the NHS: a model-based economic evaluation 

    Snowsill, TM; Moore, J; Mujica Mota, R; Peters, JL; Jones-Hughes, T; Huxley, NJ; Coelho, H; Haasova, M; Cooper, C; Lowe, JA; Varley-Campbell, J; Crathorne, L; Allwood, M; Anderson, R (Oxford University Press (OUP) for European Renal Association - European Dialysis and Transplant Association (ERA-EDTA), 2017-06-01)
    Background Immunosuppression is required in kidney transplantation to prevent rejection and prolong graft survival. We conducted an economic evaluation to support the National Institute for Health and Care Excellence in ...
  • Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. 

    Jones-Hughes, T; Snowsill, T; Haasova, M; Coelho, H; Crathorne, L; Cooper, C; Mujica-Mota, R; Peters, J; Varley-Campbell, J; Huxley, N; Moore, J; Allwood, M; Lowe, J; Hyde, C; Hoyle, M; Bond, M; Anderson, R (NIHR Health Technology Assessment Programme, 2016-08)
    BACKGROUND: End-stage renal disease is a long-term irreversible decline in kidney function requiring renal replacement therapy: kidney transplantation, haemodialysis or peritoneal dialysis. The preferred option is kidney ...